Table 1 Baseline Characteristics of patients included in this study
Characteristics | No. |
|---|---|
Age, n (%) | Â |
 < 40 | 2 (2.47) |
 40–64 | 21 (25.93) |
 65–79 | 34 (41.98) |
 ≥ 80 | 24 (29.63) |
 mean | 71.05 ± 13.01 |
Sex, n (%) | Â |
 male | 33 (40.74) |
 female | 48 (59.26) |
Number of comorbidities, n (%) | Â |
 1 | 1(1.23) |
 ≥ 2 and <5 | 25(30.86) |
 ≥ 5 | 55 (67.90) |
Types of comorbidities*, n (%) | Â |
 Hyperlipidemia | 54 (66.67) |
 Coronary heart disease | 32 (39.51) |
 Hypertension | 32 (39.51) |
 Cerebral infarction | 21 (25.93) |
 Diabetes | 17 (20.99) |
 Hyperuricemia / gout | 12 (14.81) |
 Sleep disorders | 11 (13.58) |
 Arthritis | 11 (13.58) |
 Osteoporosis | 11 (13.58) |
 Peripheral neuropathy | 10 (12.35) |
Number of combined drugs, n (%) | Â |
 1–4 | 14 (17.28) |
 5–9 | 36 (44.44) |
 ≥ 10 | 31 (38.27) |